| 1 | monotherapy | 7,775 |
| 2 | medoxomil | 339 |
| 3 | monotherapies | 257 |
| 4 | cilexetil | 183 |
| 5 | mesylate | 166 |
| 6 | gits | 133 |
| 7 | decanoate | 131 |
| 8 | dipivoxil | 116 |
| 9 | besylate | 96 |
| 10 | cr/xl | 91 |
| 11 | hippurate | 81 |
| 12 | mono-therapy | 70 |
| 13 | handihaler | 58 |
| 14 | disilicate | 50 |
| 15 | bisulfate | 45 |
| 16 | octanoate | 43 |
| 17 | emtansine | 40 |
| 18 | chronotherapy | 39 |
| 19 | reload | 32 |
| 20 | cr/zok | 28 |
| 21 | hexa | 28 |
| 22 | resinate | 28 |
| 23 | respimat® | 24 |
| 24 | co-substrate | 22 |
| 25 | cotherapy | 20 |
| 26 | er/lovastatin | 20 |
| 27 | semisodium | 17 |
| 28 | bak-free | 16 |
| 29 | sr/trandolapril | 16 |
| 30 | methionil | 15 |
| 31 | napadisilate | 15 |
| 32 | niobate | 15 |
| 33 | aceturate | 14 |
| 34 | sr-trandolapril | 14 |
| 35 | jie-ji | 13 |
| 36 | medoxomil/chlorthalidone | 13 |
| 37 | medoxomil/hydrochlorothiazide | 13 |
| 38 | monochemotherapy | 13 |
| 39 | dipotassium | 12 |
| 40 | jumpstart | 12 |
| 41 | tosilate | 12 |
| 42 | besylate/benazepril | 11 |
| 43 | autogel | 10 |
| 44 | bicm | 10 |
| 45 | cdmards | 10 |
| 46 | 50mg/d | 9 |
| 47 | 7.5mg/kg | 9 |
| 48 | bisulphate | 9 |
| 49 | 200mg/m | 8 |
| 50 | 21-phosphate | 8 |
| 51 | cilexitil | 8 |
| 52 | extended-release/lovastatin | 8 |
| 53 | medoxomil/amlodipine | 8 |
| 54 | bismesylate | 7 |
| 55 | daloxate | 7 |
| 56 | mono-treatment | 7 |
| 57 | phenylglycosides | 7 |
| 58 | sr- | 7 |
| 59 | vasilip | 7 |
| 60 | hydroimidazolone | 6 |
| 61 | lavomax | 6 |
| 62 | lemuru | 6 |
| 63 | liniment | 6 |
| 64 | non-escalators | 6 |
| 65 | nonrelevant | 6 |
| 66 | penicillin-gentamicin | 6 |
| 67 | poliglumex | 6 |
| 68 | polyglutamates | 6 |
| 69 | treated-xo | 6 |
| 70 | vataka | 6 |
| 71 | 1000mg/m | 5 |
| 72 | 2000iu | 5 |
| 73 | 3-o-glucuronide | 5 |
| 74 | 50▒mg/day | 5 |
| 75 | 55μg | 5 |
| 76 | camsylate/losartan | 5 |
| 77 | cipecilate | 5 |
| 78 | erbumine | 5 |
| 79 | gits/oros | 5 |
| 80 | hc1 | 5 |
| 81 | n-glucuronide | 5 |
| 82 | treated-initial | 5 |
| 83 | trifenatate | 5 |
| 84 | umckaloabo | 5 |
| 85 | 0.1mg/kg/day | 4 |
| 86 | 10mg/10mg | 4 |
| 87 | 10mg/d | 4 |
| 88 | 40-mg/d | 4 |
| 89 | 5mg/d | 4 |
| 90 | 6.25-mg | 4 |
| 91 | 60mg/m | 4 |
| 92 | beclamide | 4 |
| 93 | brainwork | 4 |
| 94 | cholinergics | 4 |
| 95 | cilexetil/hydrochlorothiazide | 4 |
| 96 | cr-based | 4 |
| 97 | cr/lisinopril | 4 |
| 98 | ferrograd® | 4 |
| 99 | ifnα-2a | 4 |
| 100 | induction-chemotherapy | 4 |
| 101 | jiaonang | 4 |
| 102 | medoxomil/hctz | 4 |
| 103 | monotreatment | 4 |
| 104 | napsylate | 4 |
| 105 | ornamentals | 4 |
| 106 | short-sightedness | 4 |
| 107 | sinu-foam™ | 4 |
| 108 | v35 | 4 |
| 109 | 10/simvastatin | 3 |
| 110 | 125/80mg | 3 |
| 111 | 150mg/m | 3 |
| 112 | 200u | 3 |
| 113 | 70mg/m | 3 |
| 114 | acylases | 3 |
| 115 | adipate/valsartan | 3 |
| 116 | arrest/incarceration | 3 |
| 117 | beta-treated | 3 |
| 118 | caligodes | 3 |
| 119 | capsule/sprinkles | 3 |
| 120 | controlled-release/extended-release | 3 |
| 121 | dbmib | 3 |
| 122 | diacetylmidecamycin | 3 |
| 123 | emmenagogues | 3 |
| 124 | enoxaparin/warfarin | 3 |
| 125 | fosamil-avibactam | 3 |
| 126 | hyalubrix | 3 |
| 127 | insl7 | 3 |
| 128 | junior® | 3 |
| 129 | liposme | 3 |
| 130 | montherapy | 3 |
| 131 | namfp | 3 |
| 132 | pharmacoenhancers | 3 |
| 133 | pic® | 3 |
| 134 | single-dosed | 3 |
| 135 | sr-based | 3 |
| 136 | trihydrochloride | 3 |
| 137 | zefxon | 3 |
| 138 | 0.25mg/d | 2 |
| 139 | 1.8g/day | 2 |
| 140 | 10/20mg | 2 |
| 141 | 1000mg/m2 | 2 |
| 142 | 125i-cyanopindolol | 2 |
| 143 | 175mg/m² | 2 |
| 144 | 2-amino-4-methyl-3-nitro-6 | 2 |
| 145 | 2-aminofluorene | 2 |
| 146 | 20-mg/ce | 2 |
| 147 | 20mg-bid | 2 |
| 148 | 24/141 | 2 |
| 149 | 2400-mg/d | 2 |
| 150 | 2mg/indapamide | 2 |
| 151 | 360mg | 2 |
| 152 | 40-/20-mg | 2 |
| 153 | 60-yr-old | 2 |
| 154 | 60mg/m²/day | 2 |
| 155 | 75-mg/m | 2 |
| 156 | 85mg/m | 2 |
| 157 | ace-blockade | 2 |
| 158 | anabaenopeptins | 2 |
| 159 | antidiarrhoeals | 2 |
| 160 | avishan-e-shirazi | 2 |
| 161 | based-regimens | 2 |
| 162 | besylate/benazapril | 2 |
| 163 | bromide/formoterol | 2 |
| 164 | ceftriaxone/metronidazole | 2 |
| 165 | chondroma | 2 |
| 166 | cilexetil-treated | 2 |
| 167 | diaceturate | 2 |
| 168 | dose= | 2 |
| 169 | duo™ | 2 |
| 170 | g18 | 2 |
| 171 | haart+maraviroc | 2 |
| 172 | hcl-ezetimibe | 2 |
| 173 | hcl-treated | 2 |
| 174 | hcl/ezetimibe | 2 |
| 175 | hfd+lps | 2 |
| 176 | hydrogensulfate | 2 |
| 177 | hydrosonography | 2 |
| 178 | induction- | 2 |
| 179 | iodate/day | 2 |
| 180 | ly3009104 | 2 |
| 181 | mkk-3 | 2 |
| 182 | neurod1 | 2 |
| 183 | neuroinfections | 2 |
| 184 | non-seekers | 2 |
| 185 | once/month | 2 |
| 186 | phosphate-trimethoprim | 2 |
| 187 | pramlintide/metreleptin | 2 |
| 188 | recipients.black | 2 |
| 189 | rs28757581 | 2 |
| 190 | sax×c18 | 2 |
| 191 | scd16 | 2 |
| 192 | sil-8 | 2 |
| 193 | stutters | 2 |
| 194 | suppository.physical | 2 |
| 195 | td-rs | 2 |
| 196 | thcfas | 2 |
| 197 | therapy-which | 2 |
| 198 | tnfis/methotrexate | 2 |
| 199 | ttto | 2 |
| 200 | vitalism | 2 |
| 201 | δtt | 2 |
| 202 | +amodiaquine | 1 |
| 203 | +i/r | 1 |
| 204 | -0.68±1.45 | 1 |
| 205 | -221.8 | 1 |
| 206 | -2·18 | 1 |
| 207 | -57.78 | 1 |
| 208 | -capecitabine | 1 |
| 209 | /digoxin | 1 |
| 210 | 0.45-mg | 1 |
| 211 | 0.5-1.0mg/day | 1 |
| 212 | 0·805 | 1 |
| 213 | 1,1,1,3,3,3-hexa-fluoro-2-methyl-2-propoxide | 1 |
| 214 | 1.3mg/m | 1 |
| 215 | 10-40mg/day | 1 |
| 216 | 10/60mg/day | 1 |
| 217 | 100/m | 1 |
| 218 | 1000-1200-mg/qd | 1 |
| 219 | 100mg/mq | 1 |
| 220 | 100mg/week | 1 |
| 221 | 10mg+simvastatin | 1 |
| 222 | 10ug | 1 |
| 223 | 10μg/day | 1 |
| 224 | 12-mg/kg | 1 |
| 225 | 13.4±5 | 1 |
| 226 | 150/5mg | 1 |
| 227 | 156/102 | 1 |
| 228 | 15mg/m | 1 |
| 229 | 175-mg | 1 |
| 230 | 1g/20mg+simva | 1 |
| 231 | 1gr/day | 1 |
| 232 | 2-am | 1 |
| 233 | 20,40 | 1 |
| 234 | 20-120mg/d | 1 |
| 235 | 20mgbid | 1 |
| 236 | 217.1±84.7 | 1 |
| 237 | 221.0±87.3 | 1 |
| 238 | 226.4±79.3 | 1 |
| 239 | 227±84 | 1 |
| 240 | 2400mg/m2 | 1 |
| 241 | 241.5±88.2 | 1 |
| 242 | 250mg/m | 1 |
| 243 | 2g/m | 1 |
| 244 | 2n4 | 1 |
| 245 | 3'-c-ethinylcytidine | 1 |
| 246 | 3.1858 | 1 |
| 247 | 3.4381 | 1 |
| 248 | 3.9+/-6.6 | 1 |
| 249 | 30mg/m | 1 |
| 250 | 35.0±2.0 | 1 |
| 251 | 35/13/2/0 | 1 |
| 252 | 3x400mg | 1 |
| 253 | 4.05-fold | 1 |
| 254 | 40-mg/m | 1 |
| 255 | 400-mg/m | 1 |
| 256 | 46/1170 | 1 |
| 257 | 47.9/24.8 | 1 |
| 258 | 48/1,287 | 1 |
| 259 | 4mg/24h | 1 |
| 260 | 5'triphosphate | 1 |
| 261 | 5-formyltetrahydrofolate | 1 |
| 262 | 5.6±1.8 | 1 |
| 263 | 50-200mg/day | 1 |
| 264 | 50/100mg | 1 |
| 265 | 600mg/m | 1 |
| 266 | 68°f | 1 |
| 267 | 6α-hydroxylation | 1 |
| 268 | 750mg/m | 1 |
| 269 | 8-mg/d | 1 |
| 270 | 80/800 | 1 |
| 271 | 825mg/m | 1 |
| 272 | 9mg/m | 1 |
| 273 | abacavir/lamivudine/tenofovir | 1 |
| 274 | ac-yvad-cho | 1 |
| 275 | active-metabolite | 1 |
| 276 | alanyl-alanine | 1 |
| 277 | alone.clinical | 1 |
| 278 | alone.currently | 1 |
| 279 | alone.two | 1 |
| 280 | alpha-naphthoflavone | 1 |
| 281 | aminoglutethimid | 1 |
| 282 | angptl6/arp5 | 1 |
| 283 | antiischaemia | 1 |
| 284 | apl180 | 1 |
| 285 | articular- | 1 |
| 286 | attention-strategy | 1 |
| 287 | auc0-14d | 1 |
| 288 | auc4 | 1 |
| 289 | aurita | 1 |
| 290 | basal-alone | 1 |
| 291 | bazuco | 1 |
| 292 | bms309403 | 1 |
| 293 | bromide/indacaterol | 1 |
| 294 | bta9881 | 1 |
| 295 | by3.4- | 1 |
| 296 | c+3953c | 1 |
| 297 | cabg- | 1 |
| 298 | calpeptin | 1 |
| 299 | carbonate-alphacalcidol | 1 |
| 300 | carmelo | 1 |
| 301 | cayston® | 1 |
| 302 | celgene® | 1 |
| 303 | chak2 | 1 |
| 304 | chemotherapy+/-sirt | 1 |
| 305 | chloroma | 1 |
| 306 | cilexeil | 1 |
| 307 | cilexitil-treated | 1 |
| 308 | cin-3 | 1 |
| 309 | cisplatin/vindesine | 1 |
| 310 | citrate/placebo | 1 |
| 311 | cmpd1 | 1 |
| 312 | co-dergocrine | 1 |
| 313 | coarticulation | 1 |
| 314 | continuous/indwelling | 1 |
| 315 | cosaar | 1 |
| 316 | cpuyl064 | 1 |
| 317 | ct99021 | 1 |
| 318 | cyclina2 | 1 |
| 319 | cyklo-f | 1 |
| 320 | decanoate-treated | 1 |
| 321 | decaonate | 1 |
| 322 | dipivoxyl | 1 |
| 323 | diprivoxil | 1 |
| 324 | discontinu* | 1 |
| 325 | ditosylate | 1 |
| 326 | dna-methylating | 1 |
| 327 | dopamine-modified | 1 |
| 328 | doublet-chemotherapy | 1 |
| 329 | du-positive | 1 |
| 330 | dystroglycanopathy | 1 |
| 331 | elacrider | 1 |
| 332 | elavl1 | 1 |
| 333 | estradiol/dydrogesterone | 1 |
| 334 | estrogen-agonists | 1 |
| 335 | evals | 1 |
| 336 | exposure-survival | 1 |
| 337 | extract-a | 1 |
| 338 | fam208a | 1 |
| 339 | feed-in-tariffs | 1 |
| 340 | fissura | 1 |
| 341 | flatland | 1 |
| 342 | follows-control | 1 |
| 343 | follows:1 | 1 |
| 344 | frax™ | 1 |
| 345 | gallamine | 1 |
| 346 | gdp-β-s | 1 |
| 347 | gemcitabine/epirubicin/paclitaxel | 1 |
| 348 | gf-sd | 1 |
| 349 | gpsm1 | 1 |
| 350 | ground-ivy | 1 |
| 351 | group.ciclesonide | 1 |
| 352 | group=88 | 1 |
| 353 | h-rev107-1 | 1 |
| 354 | havcr2 | 1 |
| 355 | health-affirming | 1 |
| 356 | hexa/infanrix-ipv+hib | 1 |
| 357 | hexa™ | 1 |
| 358 | high-equipotency | 1 |
| 359 | hivep3 | 1 |
| 360 | hna-1a/-1b/-1c | 1 |
| 361 | hnrs | 1 |
| 362 | hrk | 1 |
| 363 | hydorocholoride | 1 |
| 364 | hydro-imidazolinones | 1 |
| 365 | hydrochloride/naltrindole/nor-binaltorphimine | 1 |
| 366 | hyroxycarbamide | 1 |
| 367 | inhibitor-9 | 1 |
| 368 | ipv+hib | 1 |
| 369 | irct201208022812n9 | 1 |
| 370 | isrctn37109430 | 1 |
| 371 | iv3000® | 1 |
| 372 | jhahoo | 1 |
| 373 | jhdm2a | 1 |
| 374 | kcc-009 | 1 |
| 375 | korarchaeota-optimal | 1 |
| 376 | kti11 | 1 |
| 377 | kusayr | 1 |
| 378 | l-semet | 1 |
| 379 | lactone-were | 1 |
| 380 | ld+md | 1 |
| 381 | liposom | 1 |
| 382 | liv-1 | 1 |
| 383 | maassel | 1 |
| 384 | maderensis | 1 |
| 385 | maleate/metformin | 1 |
| 386 | malnourished.a | 1 |
| 387 | malposed | 1 |
| 388 | mastranto | 1 |
| 389 | mdivi-1 | 1 |
| 390 | methyl-glucopyranoside | 1 |
| 391 | microbe- | 1 |
| 392 | middle-outcome | 1 |
| 393 | misai | 1 |
| 394 | monotheray | 1 |
| 395 | n=2618 | 1 |
| 396 | nb16 | 1 |
| 397 | nct00944749 | 1 |
| 398 | nct01401296 | 1 |
| 399 | nonheterosexual | 1 |
| 400 | nuromol | 1 |
| 401 | obscurations | 1 |
| 402 | occurs-that | 1 |
| 403 | ok-704 | 1 |
| 404 | one-/two-step/placebo | 1 |
| 405 | only-treated | 1 |
| 406 | opatanol | 1 |
| 407 | optflux | 1 |
| 408 | oxacillin-dicloxacillin | 1 |
| 409 | oxide/proteinate | 1 |
| 410 | pau-ferro | 1 |
| 411 | pd173074 | 1 |
| 412 | pdt/placebo | 1 |
| 413 | peer-mediation | 1 |
| 414 | pegfp-mstnpro-intron1 | 1 |
| 415 | pemtumomab | 1 |
| 416 | pentacarinat | 1 |
| 417 | pinteraction=0·0066 | 1 |
| 418 | platelet-depletion | 1 |
| 419 | pmws-affected | 1 |
| 420 | polar-nonpolar | 1 |
| 421 | progression/event | 1 |
| 422 | ps1145 | 1 |
| 423 | psychohygienic | 1 |
| 424 | ptn2 | 1 |
| 425 | pyrimetamine | 1 |
| 426 | qdb | 1 |
| 427 | retreatment/prednisone/custirsen | 1 |
| 428 | rs-61443 | 1 |
| 429 | saccarine | 1 |
| 430 | sarha | 1 |
| 431 | seprase | 1 |
| 432 | sheikhs | 1 |
| 433 | smptsc | 1 |
| 434 | so-shi-ho-tang | 1 |
| 435 | sulfapyrazone | 1 |
| 436 | sulfate/lamivudine | 1 |
| 437 | sustained-release- | 1 |
| 438 | tanacha | 1 |
| 439 | teb4 | 1 |
| 440 | therapeutx | 1 |
| 441 | therapy.l-dopa | 1 |
| 442 | thshsp1-9 | 1 |
| 443 | tinuvin-622 | 1 |
| 444 | tmos-treated | 1 |
| 445 | treated-initial/ranibizumab | 1 |
| 446 | treated-rats | 1 |
| 447 | tribenzoate | 1 |
| 448 | trim28 | 1 |
| 449 | tris-ulfide | 1 |
| 450 | tropanediol | 1 |
| 451 | trp-plik | 1 |
| 452 | uptitration/ezetimibe | 1 |
| 453 | v285 | 1 |
| 454 | varus- | 1 |
| 455 | vesnarininone | 1 |
| 456 | vivitrol® | 1 |
| 457 | vv5gt3 | 1 |
| 458 | xl/hctz | 1 |
| 459 | xl/hydrochlorothiazide | 1 |
| 460 | ybbp | 1 |
| 461 | zdevd-fmk | 1 |
| 462 | ¿ncct¿ | 1 |
| 463 | α-o- | 1 |
| 464 | β2-microglobulin-free | 1 |
| 465 | €3453 | 1 |
| 466 | ≥50mg | 1 |
| 1 | +amodiaquine | 1 |
| 2 | +i/r | 1 |
| 3 | -0.68±1.45 | 1 |
| 4 | -221.8 | 1 |
| 5 | -2·18 | 1 |
| 6 | -57.78 | 1 |
| 7 | -capecitabine | 1 |
| 8 | /digoxin | 1 |
| 9 | 0.1mg/kg/day | 4 |
| 10 | 0.25mg/d | 2 |
| 11 | 0.45-mg | 1 |
| 12 | 0.5-1.0mg/day | 1 |
| 13 | 0·805 | 1 |
| 14 | 1,1,1,3,3,3-hexa-fluoro-2-methyl-2-propoxide | 1 |
| 15 | 1.3mg/m | 1 |
| 16 | 1.8g/day | 2 |
| 17 | 10-40mg/day | 1 |
| 18 | 10/20mg | 2 |
| 19 | 10/60mg/day | 1 |
| 20 | 10/simvastatin | 3 |
| 21 | 100/m | 1 |
| 22 | 1000-1200-mg/qd | 1 |
| 23 | 1000mg/m | 5 |
| 24 | 1000mg/m2 | 2 |
| 25 | 100mg/mq | 1 |
| 26 | 100mg/week | 1 |
| 27 | 10mg+simvastatin | 1 |
| 28 | 10mg/10mg | 4 |
| 29 | 10mg/d | 4 |
| 30 | 10ug | 1 |
| 31 | 10μg/day | 1 |
| 32 | 12-mg/kg | 1 |
| 33 | 125/80mg | 3 |
| 34 | 125i-cyanopindolol | 2 |
| 35 | 13.4±5 | 1 |
| 36 | 150/5mg | 1 |
| 37 | 150mg/m | 3 |
| 38 | 156/102 | 1 |
| 39 | 15mg/m | 1 |
| 40 | 175-mg | 1 |
| 41 | 175mg/m² | 2 |
| 42 | 1g/20mg+simva | 1 |
| 43 | 1gr/day | 1 |
| 44 | 2-am | 1 |
| 45 | 2-amino-4-methyl-3-nitro-6 | 2 |
| 46 | 2-aminofluorene | 2 |
| 47 | 20,40 | 1 |
| 48 | 20-120mg/d | 1 |
| 49 | 20-mg/ce | 2 |
| 50 | 2000iu | 5 |
| 51 | 200mg/m | 8 |
| 52 | 200u | 3 |
| 53 | 20mg-bid | 2 |
| 54 | 20mgbid | 1 |
| 55 | 21-phosphate | 8 |
| 56 | 217.1±84.7 | 1 |
| 57 | 221.0±87.3 | 1 |
| 58 | 226.4±79.3 | 1 |
| 59 | 227±84 | 1 |
| 60 | 24/141 | 2 |
| 61 | 2400-mg/d | 2 |
| 62 | 2400mg/m2 | 1 |
| 63 | 241.5±88.2 | 1 |
| 64 | 250mg/m | 1 |
| 65 | 2g/m | 1 |
| 66 | 2mg/indapamide | 2 |
| 67 | 2n4 | 1 |
| 68 | 3'-c-ethinylcytidine | 1 |
| 69 | 3-o-glucuronide | 5 |
| 70 | 3.1858 | 1 |
| 71 | 3.4381 | 1 |
| 72 | 3.9+/-6.6 | 1 |
| 73 | 30mg/m | 1 |
| 74 | 35.0±2.0 | 1 |
| 75 | 35/13/2/0 | 1 |
| 76 | 360mg | 2 |
| 77 | 3x400mg | 1 |
| 78 | 4.05-fold | 1 |
| 79 | 40-/20-mg | 2 |
| 80 | 40-mg/d | 4 |
| 81 | 40-mg/m | 1 |
| 82 | 400-mg/m | 1 |
| 83 | 46/1170 | 1 |
| 84 | 47.9/24.8 | 1 |
| 85 | 48/1,287 | 1 |
| 86 | 4mg/24h | 1 |
| 87 | 5'triphosphate | 1 |
| 88 | 5-formyltetrahydrofolate | 1 |
| 89 | 5.6±1.8 | 1 |
| 90 | 50-200mg/day | 1 |
| 91 | 50/100mg | 1 |
| 92 | 50mg/d | 9 |
| 93 | 50▒mg/day | 5 |
| 94 | 55μg | 5 |
| 95 | 5mg/d | 4 |
| 96 | 6.25-mg | 4 |
| 97 | 60-yr-old | 2 |
| 98 | 600mg/m | 1 |
| 99 | 60mg/m | 4 |
| 100 | 60mg/m²/day | 2 |
| 101 | 68°f | 1 |
| 102 | 6α-hydroxylation | 1 |
| 103 | 7.5mg/kg | 9 |
| 104 | 70mg/m | 3 |
| 105 | 75-mg/m | 2 |
| 106 | 750mg/m | 1 |
| 107 | 8-mg/d | 1 |
| 108 | 80/800 | 1 |
| 109 | 825mg/m | 1 |
| 110 | 85mg/m | 2 |
| 111 | 9mg/m | 1 |
| 112 | abacavir/lamivudine/tenofovir | 1 |
| 113 | ac-yvad-cho | 1 |
| 114 | ace-blockade | 2 |
| 115 | aceturate | 14 |
| 116 | active-metabolite | 1 |
| 117 | acylases | 3 |
| 118 | adipate/valsartan | 3 |
| 119 | alanyl-alanine | 1 |
| 120 | alone.clinical | 1 |
| 121 | alone.currently | 1 |
| 122 | alone.two | 1 |
| 123 | alpha-naphthoflavone | 1 |
| 124 | aminoglutethimid | 1 |
| 125 | anabaenopeptins | 2 |
| 126 | angptl6/arp5 | 1 |
| 127 | antidiarrhoeals | 2 |
| 128 | antiischaemia | 1 |
| 129 | apl180 | 1 |
| 130 | arrest/incarceration | 3 |
| 131 | articular- | 1 |
| 132 | attention-strategy | 1 |
| 133 | auc0-14d | 1 |
| 134 | auc4 | 1 |
| 135 | aurita | 1 |
| 136 | autogel | 10 |
| 137 | avishan-e-shirazi | 2 |
| 138 | bak-free | 16 |
| 139 | basal-alone | 1 |
| 140 | based-regimens | 2 |
| 141 | bazuco | 1 |
| 142 | beclamide | 4 |
| 143 | besylate | 96 |
| 144 | besylate/benazapril | 2 |
| 145 | besylate/benazepril | 11 |
| 146 | beta-treated | 3 |
| 147 | bicm | 10 |
| 148 | bismesylate | 7 |
| 149 | bisulfate | 45 |
| 150 | bisulphate | 9 |
| 151 | bms309403 | 1 |
| 152 | brainwork | 4 |
| 153 | bromide/formoterol | 2 |
| 154 | bromide/indacaterol | 1 |
| 155 | bta9881 | 1 |
| 156 | by3.4- | 1 |
| 157 | c+3953c | 1 |
| 158 | cabg- | 1 |
| 159 | caligodes | 3 |
| 160 | calpeptin | 1 |
| 161 | camsylate/losartan | 5 |
| 162 | capsule/sprinkles | 3 |
| 163 | carbonate-alphacalcidol | 1 |
| 164 | carmelo | 1 |
| 165 | cayston® | 1 |
| 166 | cdmards | 10 |
| 167 | ceftriaxone/metronidazole | 2 |
| 168 | celgene® | 1 |
| 169 | chak2 | 1 |
| 170 | chemotherapy+/-sirt | 1 |
| 171 | chloroma | 1 |
| 172 | cholinergics | 4 |
| 173 | chondroma | 2 |
| 174 | chronotherapy | 39 |
| 175 | cilexeil | 1 |
| 176 | cilexetil | 183 |
| 177 | cilexetil-treated | 2 |
| 178 | cilexetil/hydrochlorothiazide | 4 |
| 179 | cilexitil | 8 |
| 180 | cilexitil-treated | 1 |
| 181 | cin-3 | 1 |
| 182 | cipecilate | 5 |
| 183 | cisplatin/vindesine | 1 |
| 184 | citrate/placebo | 1 |
| 185 | cmpd1 | 1 |
| 186 | co-dergocrine | 1 |
| 187 | co-substrate | 22 |
| 188 | coarticulation | 1 |
| 189 | continuous/indwelling | 1 |
| 190 | controlled-release/extended-release | 3 |
| 191 | cosaar | 1 |
| 192 | cotherapy | 20 |
| 193 | cpuyl064 | 1 |
| 194 | cr-based | 4 |
| 195 | cr/lisinopril | 4 |
| 196 | cr/xl | 91 |
| 197 | cr/zok | 28 |
| 198 | ct99021 | 1 |
| 199 | cyclina2 | 1 |
| 200 | cyklo-f | 1 |
| 201 | daloxate | 7 |
| 202 | dbmib | 3 |
| 203 | decanoate | 131 |
| 204 | decanoate-treated | 1 |
| 205 | decaonate | 1 |
| 206 | diaceturate | 2 |
| 207 | diacetylmidecamycin | 3 |
| 208 | dipivoxil | 116 |
| 209 | dipivoxyl | 1 |
| 210 | dipotassium | 12 |
| 211 | diprivoxil | 1 |
| 212 | discontinu* | 1 |
| 213 | disilicate | 50 |
| 214 | ditosylate | 1 |
| 215 | dna-methylating | 1 |
| 216 | dopamine-modified | 1 |
| 217 | dose= | 2 |
| 218 | doublet-chemotherapy | 1 |
| 219 | du-positive | 1 |
| 220 | duo™ | 2 |
| 221 | dystroglycanopathy | 1 |
| 222 | elacrider | 1 |
| 223 | elavl1 | 1 |
| 224 | emmenagogues | 3 |
| 225 | emtansine | 40 |
| 226 | enoxaparin/warfarin | 3 |
| 227 | er/lovastatin | 20 |
| 228 | erbumine | 5 |
| 229 | estradiol/dydrogesterone | 1 |
| 230 | estrogen-agonists | 1 |
| 231 | evals | 1 |
| 232 | exposure-survival | 1 |
| 233 | extended-release/lovastatin | 8 |
| 234 | extract-a | 1 |
| 235 | fam208a | 1 |
| 236 | feed-in-tariffs | 1 |
| 237 | ferrograd® | 4 |
| 238 | fissura | 1 |
| 239 | flatland | 1 |
| 240 | follows-control | 1 |
| 241 | follows:1 | 1 |
| 242 | fosamil-avibactam | 3 |
| 243 | frax™ | 1 |
| 244 | g18 | 2 |
| 245 | gallamine | 1 |
| 246 | gdp-β-s | 1 |
| 247 | gemcitabine/epirubicin/paclitaxel | 1 |
| 248 | gf-sd | 1 |
| 249 | gits | 133 |
| 250 | gits/oros | 5 |
| 251 | gpsm1 | 1 |
| 252 | ground-ivy | 1 |
| 253 | group.ciclesonide | 1 |
| 254 | group=88 | 1 |
| 255 | h-rev107-1 | 1 |
| 256 | haart+maraviroc | 2 |
| 257 | handihaler | 58 |
| 258 | havcr2 | 1 |
| 259 | hc1 | 5 |
| 260 | hcl-ezetimibe | 2 |
| 261 | hcl-treated | 2 |
| 262 | hcl/ezetimibe | 2 |
| 263 | health-affirming | 1 |
| 264 | hexa | 28 |
| 265 | hexa/infanrix-ipv+hib | 1 |
| 266 | hexa™ | 1 |
| 267 | hfd+lps | 2 |
| 268 | high-equipotency | 1 |
| 269 | hippurate | 81 |
| 270 | hivep3 | 1 |
| 271 | hna-1a/-1b/-1c | 1 |
| 272 | hnrs | 1 |
| 273 | hrk | 1 |
| 274 | hyalubrix | 3 |
| 275 | hydorocholoride | 1 |
| 276 | hydro-imidazolinones | 1 |
| 277 | hydrochloride/naltrindole/nor-binaltorphimine | 1 |
| 278 | hydrogensulfate | 2 |
| 279 | hydroimidazolone | 6 |
| 280 | hydrosonography | 2 |
| 281 | hyroxycarbamide | 1 |
| 282 | ifnα-2a | 4 |
| 283 | induction- | 2 |
| 284 | induction-chemotherapy | 4 |
| 285 | inhibitor-9 | 1 |
| 286 | insl7 | 3 |
| 287 | iodate/day | 2 |
| 288 | ipv+hib | 1 |
| 289 | irct201208022812n9 | 1 |
| 290 | isrctn37109430 | 1 |
| 291 | iv3000® | 1 |
| 292 | jhahoo | 1 |
| 293 | jhdm2a | 1 |
| 294 | jiaonang | 4 |
| 295 | jie-ji | 13 |
| 296 | jumpstart | 12 |
| 297 | junior® | 3 |
| 298 | kcc-009 | 1 |
| 299 | korarchaeota-optimal | 1 |
| 300 | kti11 | 1 |
| 301 | kusayr | 1 |
| 302 | l-semet | 1 |
| 303 | lactone-were | 1 |
| 304 | lavomax | 6 |
| 305 | ld+md | 1 |
| 306 | lemuru | 6 |
| 307 | liniment | 6 |
| 308 | liposme | 3 |
| 309 | liposom | 1 |
| 310 | liv-1 | 1 |
| 311 | ly3009104 | 2 |
| 312 | maassel | 1 |
| 313 | maderensis | 1 |
| 314 | maleate/metformin | 1 |
| 315 | malnourished.a | 1 |
| 316 | malposed | 1 |
| 317 | mastranto | 1 |
| 318 | mdivi-1 | 1 |
| 319 | medoxomil | 339 |
| 320 | medoxomil/amlodipine | 8 |
| 321 | medoxomil/chlorthalidone | 13 |
| 322 | medoxomil/hctz | 4 |
| 323 | medoxomil/hydrochlorothiazide | 13 |
| 324 | mesylate | 166 |
| 325 | methionil | 15 |
| 326 | methyl-glucopyranoside | 1 |
| 327 | microbe- | 1 |
| 328 | middle-outcome | 1 |
| 329 | misai | 1 |
| 330 | mkk-3 | 2 |
| 331 | mono-therapy | 70 |
| 332 | mono-treatment | 7 |
| 333 | monochemotherapy | 13 |
| 334 | monotherapies | 257 |
| 335 | monotherapy | 7,775 |
| 336 | monotheray | 1 |
| 337 | monotreatment | 4 |
| 338 | montherapy | 3 |
| 339 | n-glucuronide | 5 |
| 340 | n=2618 | 1 |
| 341 | namfp | 3 |
| 342 | napadisilate | 15 |
| 343 | napsylate | 4 |
| 344 | nb16 | 1 |
| 345 | nct00944749 | 1 |
| 346 | nct01401296 | 1 |
| 347 | neurod1 | 2 |
| 348 | neuroinfections | 2 |
| 349 | niobate | 15 |
| 350 | non-escalators | 6 |
| 351 | non-seekers | 2 |
| 352 | nonheterosexual | 1 |
| 353 | nonrelevant | 6 |
| 354 | nuromol | 1 |
| 355 | obscurations | 1 |
| 356 | occurs-that | 1 |
| 357 | octanoate | 43 |
| 358 | ok-704 | 1 |
| 359 | once/month | 2 |
| 360 | one-/two-step/placebo | 1 |
| 361 | only-treated | 1 |
| 362 | opatanol | 1 |
| 363 | optflux | 1 |
| 364 | ornamentals | 4 |
| 365 | oxacillin-dicloxacillin | 1 |
| 366 | oxide/proteinate | 1 |
| 367 | pau-ferro | 1 |
| 368 | pd173074 | 1 |
| 369 | pdt/placebo | 1 |
| 370 | peer-mediation | 1 |
| 371 | pegfp-mstnpro-intron1 | 1 |
| 372 | pemtumomab | 1 |
| 373 | penicillin-gentamicin | 6 |
| 374 | pentacarinat | 1 |
| 375 | pharmacoenhancers | 3 |
| 376 | phenylglycosides | 7 |
| 377 | phosphate-trimethoprim | 2 |
| 378 | pic® | 3 |
| 379 | pinteraction=0·0066 | 1 |
| 380 | platelet-depletion | 1 |
| 381 | pmws-affected | 1 |
| 382 | polar-nonpolar | 1 |
| 383 | poliglumex | 6 |
| 384 | polyglutamates | 6 |
| 385 | pramlintide/metreleptin | 2 |
| 386 | progression/event | 1 |
| 387 | ps1145 | 1 |
| 388 | psychohygienic | 1 |
| 389 | ptn2 | 1 |
| 390 | pyrimetamine | 1 |
| 391 | qdb | 1 |
| 392 | recipients.black | 2 |
| 393 | reload | 32 |
| 394 | resinate | 28 |
| 395 | respimat® | 24 |
| 396 | retreatment/prednisone/custirsen | 1 |
| 397 | rs-61443 | 1 |
| 398 | rs28757581 | 2 |
| 399 | saccarine | 1 |
| 400 | sarha | 1 |
| 401 | sax×c18 | 2 |
| 402 | scd16 | 2 |
| 403 | semisodium | 17 |
| 404 | seprase | 1 |
| 405 | sheikhs | 1 |
| 406 | short-sightedness | 4 |
| 407 | sil-8 | 2 |
| 408 | single-dosed | 3 |
| 409 | sinu-foam™ | 4 |
| 410 | smptsc | 1 |
| 411 | so-shi-ho-tang | 1 |
| 412 | sr- | 7 |
| 413 | sr-based | 3 |
| 414 | sr-trandolapril | 14 |
| 415 | sr/trandolapril | 16 |
| 416 | stutters | 2 |
| 417 | sulfapyrazone | 1 |
| 418 | sulfate/lamivudine | 1 |
| 419 | suppository.physical | 2 |
| 420 | sustained-release- | 1 |
| 421 | tanacha | 1 |
| 422 | td-rs | 2 |
| 423 | teb4 | 1 |
| 424 | thcfas | 2 |
| 425 | therapeutx | 1 |
| 426 | therapy-which | 2 |
| 427 | therapy.l-dopa | 1 |
| 428 | thshsp1-9 | 1 |
| 429 | tinuvin-622 | 1 |
| 430 | tmos-treated | 1 |
| 431 | tnfis/methotrexate | 2 |
| 432 | tosilate | 12 |
| 433 | treated-initial | 5 |
| 434 | treated-initial/ranibizumab | 1 |
| 435 | treated-rats | 1 |
| 436 | treated-xo | 6 |
| 437 | tribenzoate | 1 |
| 438 | trifenatate | 5 |
| 439 | trihydrochloride | 3 |
| 440 | trim28 | 1 |
| 441 | tris-ulfide | 1 |
| 442 | tropanediol | 1 |
| 443 | trp-plik | 1 |
| 444 | ttto | 2 |
| 445 | umckaloabo | 5 |
| 446 | uptitration/ezetimibe | 1 |
| 447 | v285 | 1 |
| 448 | v35 | 4 |
| 449 | varus- | 1 |
| 450 | vasilip | 7 |
| 451 | vataka | 6 |
| 452 | vesnarininone | 1 |
| 453 | vitalism | 2 |
| 454 | vivitrol® | 1 |
| 455 | vv5gt3 | 1 |
| 456 | xl/hctz | 1 |
| 457 | xl/hydrochlorothiazide | 1 |
| 458 | ybbp | 1 |
| 459 | zdevd-fmk | 1 |
| 460 | zefxon | 3 |
| 461 | ¿ncct¿ | 1 |
| 462 | α-o- | 1 |
| 463 | β2-microglobulin-free | 1 |
| 464 | δtt | 2 |
| 465 | €3453 | 1 |
| 466 | ≥50mg | 1 |
| 1 | discontinu* | 1 |
| 2 | by3.4- | 1 |
| 3 | microbe- | 1 |
| 4 | sustained-release- | 1 |
| 5 | cabg- | 1 |
| 6 | induction- | 2 |
| 7 | α-o- | 1 |
| 8 | articular- | 1 |
| 9 | sr- | 7 |
| 10 | varus- | 1 |
| 11 | 35.0±2.0 | 1 |
| 12 | 35/13/2/0 | 1 |
| 13 | 80/800 | 1 |
| 14 | isrctn37109430 | 1 |
| 15 | 20,40 | 1 |
| 16 | 46/1170 | 1 |
| 17 | apl180 | 1 |
| 18 | h-rev107-1 | 1 |
| 19 | mdivi-1 | 1 |
| 20 | liv-1 | 1 |
| 21 | kti11 | 1 |
| 22 | ct99021 | 1 |
| 23 | 24/141 | 2 |
| 24 | 3.4381 | 1 |
| 25 | rs28757581 | 2 |
| 26 | bta9881 | 1 |
| 27 | follows:1 | 1 |
| 28 | hc1 | 5 |
| 29 | neurod1 | 2 |
| 30 | cmpd1 | 1 |
| 31 | elavl1 | 1 |
| 32 | gpsm1 | 1 |
| 33 | pegfp-mstnpro-intron1 | 1 |
| 34 | 241.5±88.2 | 1 |
| 35 | 156/102 | 1 |
| 36 | tinuvin-622 | 1 |
| 37 | cyclina2 | 1 |
| 38 | chak2 | 1 |
| 39 | 1000mg/m2 | 2 |
| 40 | 2400mg/m2 | 1 |
| 41 | ptn2 | 1 |
| 42 | havcr2 | 1 |
| 43 | mkk-3 | 2 |
| 44 | cin-3 | 1 |
| 45 | 221.0±87.3 | 1 |
| 46 | 226.4±79.3 | 1 |
| 47 | bms309403 | 1 |
| 48 | rs-61443 | 1 |
| 49 | €3453 | 1 |
| 50 | hivep3 | 1 |
| 51 | vv5gt3 | 1 |
| 52 | ly3009104 | 2 |
| 53 | ok-704 | 1 |
| 54 | cpuyl064 | 1 |
| 55 | pd173074 | 1 |
| 56 | 227±84 | 1 |
| 57 | teb4 | 1 |
| 58 | auc4 | 1 |
| 59 | 2n4 | 1 |
| 60 | 0·805 | 1 |
| 61 | v35 | 4 |
| 62 | -0.68±1.45 | 1 |
| 63 | ps1145 | 1 |
| 64 | v285 | 1 |
| 65 | angptl6/arp5 | 1 |
| 66 | 13.4±5 | 1 |
| 67 | 2-amino-4-methyl-3-nitro-6 | 2 |
| 68 | 3.9+/-6.6 | 1 |
| 69 | nb16 | 1 |
| 70 | scd16 | 2 |
| 71 | pinteraction=0·0066 | 1 |
| 72 | nct01401296 | 1 |
| 73 | 217.1±84.7 | 1 |
| 74 | 48/1,287 | 1 |
| 75 | insl7 | 3 |
| 76 | sil-8 | 2 |
| 77 | -221.8 | 1 |
| 78 | 5.6±1.8 | 1 |
| 79 | 47.9/24.8 | 1 |
| 80 | n=2618 | 1 |
| 81 | sax×c18 | 2 |
| 82 | g18 | 2 |
| 83 | -2·18 | 1 |
| 84 | trim28 | 1 |
| 85 | 3.1858 | 1 |
| 86 | -57.78 | 1 |
| 87 | group=88 | 1 |
| 88 | thshsp1-9 | 1 |
| 89 | inhibitor-9 | 1 |
| 90 | kcc-009 | 1 |
| 91 | nct00944749 | 1 |
| 92 | irct201208022812n9 | 1 |
| 93 | dose= | 2 |
| 94 | extract-a | 1 |
| 95 | malnourished.a | 1 |
| 96 | ifnα-2a | 4 |
| 97 | jhdm2a | 1 |
| 98 | fam208a | 1 |
| 99 | tanacha | 1 |
| 100 | sarha | 1 |
| 101 | antiischaemia | 1 |
| 102 | vataka | 6 |
| 103 | chondroma | 2 |
| 104 | chloroma | 1 |
| 105 | therapy.l-dopa | 1 |
| 106 | fissura | 1 |
| 107 | aurita | 1 |
| 108 | 1g/20mg+simva | 1 |
| 109 | hexa | 28 |
| 110 | pemtumomab | 1 |
| 111 | treated-initial/ranibizumab | 1 |
| 112 | qdb | 1 |
| 113 | ipv+hib | 1 |
| 114 | hexa/infanrix-ipv+hib | 1 |
| 115 | dbmib | 3 |
| 116 | hna-1a/-1b/-1c | 1 |
| 117 | c+3953c | 1 |
| 118 | psychohygienic | 1 |
| 119 | haart+maraviroc | 2 |
| 120 | smptsc | 1 |
| 121 | 2400-mg/d | 2 |
| 122 | 40-mg/d | 4 |
| 123 | 8-mg/d | 1 |
| 124 | 10mg/d | 4 |
| 125 | 20-120mg/d | 1 |
| 126 | 50mg/d | 9 |
| 127 | 5mg/d | 4 |
| 128 | 0.25mg/d | 2 |
| 129 | auc0-14d | 1 |
| 130 | reload | 32 |
| 131 | dopamine-modified | 1 |
| 132 | cr-based | 4 |
| 133 | sr-based | 3 |
| 134 | single-dosed | 3 |
| 135 | malposed | 1 |
| 136 | beta-treated | 3 |
| 137 | decanoate-treated | 1 |
| 138 | hcl-treated | 2 |
| 139 | cilexetil-treated | 2 |
| 140 | cilexitil-treated | 1 |
| 141 | tmos-treated | 1 |
| 142 | only-treated | 1 |
| 143 | pmws-affected | 1 |
| 144 | 20mg-bid | 2 |
| 145 | 20mgbid | 1 |
| 146 | aminoglutethimid | 1 |
| 147 | 60-yr-old | 2 |
| 148 | 4.05-fold | 1 |
| 149 | ld+md | 1 |
| 150 | flatland | 1 |
| 151 | 1000-1200-mg/qd | 1 |
| 152 | gf-sd | 1 |
| 153 | hcl-ezetimibe | 2 |
| 154 | hcl/ezetimibe | 2 |
| 155 | uptitration/ezetimibe | 1 |
| 156 | 20-mg/ce | 2 |
| 157 | ace-blockade | 2 |
| 158 | tris-ulfide | 1 |
| 159 | hyroxycarbamide | 1 |
| 160 | beclamide | 4 |
| 161 | 2mg/indapamide | 2 |
| 162 | n-glucuronide | 5 |
| 163 | 3-o-glucuronide | 5 |
| 164 | group.ciclesonide | 1 |
| 165 | trihydrochloride | 3 |
| 166 | hydorocholoride | 1 |
| 167 | methyl-glucopyranoside | 1 |
| 168 | 1,1,1,3,3,3-hexa-fluoro-2-methyl-2-propoxide | 1 |
| 169 | medoxomil/hydrochlorothiazide | 13 |
| 170 | cilexetil/hydrochlorothiazide | 4 |
| 171 | xl/hydrochlorothiazide | 1 |
| 172 | bak-free | 16 |
| 173 | β2-microglobulin-free | 1 |
| 174 | ceftriaxone/metronidazole | 2 |
| 175 | middle-outcome | 1 |
| 176 | liposme | 3 |
| 177 | 2-aminofluorene | 2 |
| 178 | -capecitabine | 1 |
| 179 | 3'-c-ethinylcytidine | 1 |
| 180 | sulfate/lamivudine | 1 |
| 181 | gallamine | 1 |
| 182 | pyrimetamine | 1 |
| 183 | hydrochloride/naltrindole/nor-binaltorphimine | 1 |
| 184 | erbumine | 5 |
| 185 | alanyl-alanine | 1 |
| 186 | medoxomil/amlodipine | 8 |
| 187 | saccarine | 1 |
| 188 | co-dergocrine | 1 |
| 189 | cisplatin/vindesine | 1 |
| 190 | emtansine | 40 |
| 191 | +amodiaquine | 1 |
| 192 | medoxomil/chlorthalidone | 13 |
| 193 | basal-alone | 1 |
| 194 | hydroimidazolone | 6 |
| 195 | vesnarininone | 1 |
| 196 | estradiol/dydrogesterone | 1 |
| 197 | alpha-naphthoflavone | 1 |
| 198 | sulfapyrazone | 1 |
| 199 | lactone-were | 1 |
| 200 | controlled-release/extended-release | 3 |
| 201 | seprase | 1 |
| 202 | niobate | 15 |
| 203 | disilicate | 50 |
| 204 | bisulfate | 45 |
| 205 | hydrogensulfate | 2 |
| 206 | bisulphate | 9 |
| 207 | 21-phosphate | 8 |
| 208 | 5'triphosphate | 1 |
| 209 | cipecilate | 5 |
| 210 | napadisilate | 15 |
| 211 | tosilate | 12 |
| 212 | 5-formyltetrahydrofolate | 1 |
| 213 | besylate | 96 |
| 214 | mesylate | 166 |
| 215 | bismesylate | 7 |
| 216 | ditosylate | 1 |
| 217 | napsylate | 4 |
| 218 | oxide/proteinate | 1 |
| 219 | resinate | 28 |
| 220 | decaonate | 1 |
| 221 | decanoate | 131 |
| 222 | octanoate | 43 |
| 223 | tribenzoate | 1 |
| 224 | co-substrate | 22 |
| 225 | hippurate | 81 |
| 226 | aceturate | 14 |
| 227 | diaceturate | 2 |
| 228 | trifenatate | 5 |
| 229 | tnfis/methotrexate | 2 |
| 230 | daloxate | 7 |
| 231 | active-metabolite | 1 |
| 232 | du-positive | 1 |
| 233 | cyklo-f | 1 |
| 234 | 68°f | 1 |
| 235 | 12-mg/kg | 1 |
| 236 | 7.5mg/kg | 9 |
| 237 | 40-/20-mg | 2 |
| 238 | 6.25-mg | 4 |
| 239 | 0.45-mg | 1 |
| 240 | 175-mg | 1 |
| 241 | 50/100mg | 1 |
| 242 | 3x400mg | 1 |
| 243 | 10mg/10mg | 4 |
| 244 | 10/20mg | 2 |
| 245 | ≥50mg | 1 |
| 246 | 360mg | 2 |
| 247 | 125/80mg | 3 |
| 248 | 150/5mg | 1 |
| 249 | jiaonang | 4 |
| 250 | so-shi-ho-tang | 1 |
| 251 | continuous/indwelling | 1 |
| 252 | health-affirming | 1 |
| 253 | dna-methylating | 1 |
| 254 | 10ug | 1 |
| 255 | 55μg | 5 |
| 256 | 4mg/24h | 1 |
| 257 | therapy-which | 2 |
| 258 | once/month | 2 |
| 259 | misai | 1 |
| 260 | jie-ji | 13 |
| 261 | avishan-e-shirazi | 2 |
| 262 | recipients.black | 2 |
| 263 | 100mg/week | 1 |
| 264 | trp-plik | 1 |
| 265 | zdevd-fmk | 1 |
| 266 | cr/zok | 28 |
| 267 | hrk | 1 |
| 268 | brainwork | 4 |
| 269 | alone.clinical | 1 |
| 270 | suppository.physical | 2 |
| 271 | treated-initial | 5 |
| 272 | korarchaeota-optimal | 1 |
| 273 | nonheterosexual | 1 |
| 274 | exposure-survival | 1 |
| 275 | autogel | 10 |
| 276 | maassel | 1 |
| 277 | gemcitabine/epirubicin/paclitaxel | 1 |
| 278 | cilexeil | 1 |
| 279 | medoxomil | 339 |
| 280 | methionil | 15 |
| 281 | sr-trandolapril | 14 |
| 282 | sr/trandolapril | 16 |
| 283 | besylate/benazapril | 2 |
| 284 | besylate/benazepril | 11 |
| 285 | cr/lisinopril | 4 |
| 286 | cilexetil | 183 |
| 287 | cilexitil | 8 |
| 288 | dipivoxil | 116 |
| 289 | diprivoxil | 1 |
| 290 | carbonate-alphacalcidol | 1 |
| 291 | tropanediol | 1 |
| 292 | 125i-cyanopindolol | 2 |
| 293 | nuromol | 1 |
| 294 | opatanol | 1 |
| 295 | bromide/indacaterol | 1 |
| 296 | bromide/formoterol | 2 |
| 297 | follows-control | 1 |
| 298 | cr/xl | 91 |
| 299 | dipivoxyl | 1 |
| 300 | 100/m | 1 |
| 301 | 2g/m | 1 |
| 302 | 400-mg/m | 1 |
| 303 | 40-mg/m | 1 |
| 304 | 75-mg/m | 2 |
| 305 | 1000mg/m | 5 |
| 306 | 200mg/m | 8 |
| 307 | 600mg/m | 1 |
| 308 | 30mg/m | 1 |
| 309 | 150mg/m | 3 |
| 310 | 250mg/m | 1 |
| 311 | 750mg/m | 1 |
| 312 | 60mg/m | 4 |
| 313 | 70mg/m | 3 |
| 314 | 1.3mg/m | 1 |
| 315 | 15mg/m | 1 |
| 316 | 825mg/m | 1 |
| 317 | 85mg/m | 2 |
| 318 | 9mg/m | 1 |
| 319 | 2-am | 1 |
| 320 | fosamil-avibactam | 3 |
| 321 | bicm | 10 |
| 322 | phosphate-trimethoprim | 2 |
| 323 | liposom | 1 |
| 324 | vitalism | 2 |
| 325 | semisodium | 17 |
| 326 | dipotassium | 12 |
| 327 | adipate/valsartan | 3 |
| 328 | camsylate/losartan | 5 |
| 329 | retreatment/prednisone/custirsen | 1 |
| 330 | penicillin-gentamicin | 6 |
| 331 | diacetylmidecamycin | 3 |
| 332 | oxacillin-dicloxacillin | 1 |
| 333 | maleate/metformin | 1 |
| 334 | enoxaparin/warfarin | 3 |
| 335 | 10mg+simvastatin | 1 |
| 336 | 10/simvastatin | 3 |
| 337 | extended-release/lovastatin | 8 |
| 338 | er/lovastatin | 20 |
| 339 | pramlintide/metreleptin | 2 |
| 340 | calpeptin | 1 |
| 341 | /digoxin | 1 |
| 342 | peer-mediation | 1 |
| 343 | coarticulation | 1 |
| 344 | 6α-hydroxylation | 1 |
| 345 | arrest/incarceration | 3 |
| 346 | platelet-depletion | 1 |
| 347 | zefxon | 3 |
| 348 | umckaloabo | 5 |
| 349 | citrate/placebo | 1 |
| 350 | one-/two-step/placebo | 1 |
| 351 | pdt/placebo | 1 |
| 352 | bazuco | 1 |
| 353 | ac-yvad-cho | 1 |
| 354 | carmelo | 1 |
| 355 | jhahoo | 1 |
| 356 | pau-ferro | 1 |
| 357 | mastranto | 1 |
| 358 | ttto | 2 |
| 359 | alone.two | 1 |
| 360 | treated-xo | 6 |
| 361 | ybbp | 1 |
| 362 | namfp | 3 |
| 363 | vasilip | 7 |
| 364 | 100mg/mq | 1 |
| 365 | +i/r | 1 |
| 366 | cosaar | 1 |
| 367 | polar-nonpolar | 1 |
| 368 | elacrider | 1 |
| 369 | handihaler | 58 |
| 370 | abacavir/lamivudine/tenofovir | 1 |
| 371 | kusayr | 1 |
| 372 | gdp-β-s | 1 |
| 373 | thcfas | 2 |
| 374 | cholinergics | 4 |
| 375 | cdmards | 10 |
| 376 | phenylglycosides | 7 |
| 377 | caligodes | 3 |
| 378 | monotherapies | 257 |
| 379 | capsule/sprinkles | 3 |
| 380 | hydro-imidazolinones | 1 |
| 381 | acylases | 3 |
| 382 | polyglutamates | 6 |
| 383 | emmenagogues | 3 |
| 384 | feed-in-tariffs | 1 |
| 385 | sheikhs | 1 |
| 386 | maderensis | 1 |
| 387 | antidiarrhoeals | 2 |
| 388 | ornamentals | 4 |
| 389 | evals | 1 |
| 390 | based-regimens | 2 |
| 391 | anabaenopeptins | 2 |
| 392 | obscurations | 1 |
| 393 | neuroinfections | 2 |
| 394 | gits/oros | 5 |
| 395 | hfd+lps | 2 |
| 396 | td-rs | 2 |
| 397 | pharmacoenhancers | 3 |
| 398 | non-seekers | 2 |
| 399 | stutters | 2 |
| 400 | hnrs | 1 |
| 401 | non-escalators | 6 |
| 402 | short-sightedness | 4 |
| 403 | treated-rats | 1 |
| 404 | gits | 133 |
| 405 | estrogen-agonists | 1 |
| 406 | occurs-that | 1 |
| 407 | pentacarinat | 1 |
| 408 | l-semet | 1 |
| 409 | nonrelevant | 6 |
| 410 | liniment | 6 |
| 411 | mono-treatment | 7 |
| 412 | monotreatment | 4 |
| 413 | progression/event | 1 |
| 414 | jumpstart | 12 |
| 415 | chemotherapy+/-sirt | 1 |
| 416 | δtt | 2 |
| 417 | 200u | 3 |
| 418 | 2000iu | 5 |
| 419 | lemuru | 6 |
| 420 | lavomax | 6 |
| 421 | poliglumex | 6 |
| 422 | hyalubrix | 3 |
| 423 | therapeutx | 1 |
| 424 | optflux | 1 |
| 425 | iodate/day | 2 |
| 426 | 1.8g/day | 2 |
| 427 | 0.1mg/kg/day | 4 |
| 428 | 0.5-1.0mg/day | 1 |
| 429 | 50-200mg/day | 1 |
| 430 | 10-40mg/day | 1 |
| 431 | 10/60mg/day | 1 |
| 432 | 50▒mg/day | 5 |
| 433 | 10μg/day | 1 |
| 434 | 1gr/day | 1 |
| 435 | 60mg/m²/day | 2 |
| 436 | monotheray | 1 |
| 437 | high-equipotency | 1 |
| 438 | attention-strategy | 1 |
| 439 | hydrosonography | 2 |
| 440 | dystroglycanopathy | 1 |
| 441 | alone.currently | 1 |
| 442 | mono-therapy | 70 |
| 443 | montherapy | 3 |
| 444 | cotherapy | 20 |
| 445 | induction-chemotherapy | 4 |
| 446 | doublet-chemotherapy | 1 |
| 447 | monochemotherapy | 13 |
| 448 | monotherapy | 7,775 |
| 449 | chronotherapy | 39 |
| 450 | ground-ivy | 1 |
| 451 | medoxomil/hctz | 4 |
| 452 | xl/hctz | 1 |
| 453 | hexa™ | 1 |
| 454 | sinu-foam™ | 4 |
| 455 | duo™ | 2 |
| 456 | frax™ | 1 |
| 457 | iv3000® | 1 |
| 458 | pic® | 3 |
| 459 | ferrograd® | 4 |
| 460 | celgene® | 1 |
| 461 | vivitrol® | 1 |
| 462 | cayston® | 1 |
| 463 | junior® | 3 |
| 464 | respimat® | 24 |
| 465 | 175mg/m² | 2 |
| 466 | ¿ncct¿ | 1 |